Chen Q, Li Y, Zhang W, Wang C, et al. Safety and efficacy of ICI plus anlotinib vs. anlotinib alone as third-line treatment in extensive-stage small cell lung cancer: a retrospective study. J Cancer Res Clin Oncol 2021 Nov 19. pii: 10.1007/s00432-021-03858.
PMID: 34797416